Skip to main content

Table 1 HCV JFH-1 neutralization assay

From: A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies

Genotype

Nba

M/Fb ratio

Age (yr)

HCV RNAc (log IU/mL)

Mean ± SDd

Rangee

1a

11

7/4

43 ± 6

5.90 ± 0.6

2.046 ± 0.671

0.926 – 3.121

1b

11

5/6

48 ± 16

6.16 ± 0.5

1.747 ± 0.462

0.934 – 2.356

2

11

9/2

63 ± 12

5.50 ± 0.9

2.128 ± 0.365

1.486 – 2.742

3

12

8/4

40 ± 11

5.66 ± 0.6

2.148 ± 0.478

1.326 – 2.977

4

10

4/6

45 ± 11

6.07 ± 0.7

1.786 ± 0.236

1.453 – 2.152

5

2

1/1

66 ± 14

6.06 ± 0.6

1.755 ± 0.005

nd

all

57

34/23

48 ± 15

5.83 ± 0.7

1.970 ± 0.491

0.934 – 3.121

  1. aNumber of samples tested.
  2. bF, female; M, male.
  3. cHCV RNA measured using the Amplicor HCV Monitor assay, version 2.0 (Roche Diagnostics, Meylan, France) and expressed in log equivalents of IU/mL.
  4. dNeutralizing anti-HCV antibodies titers expressed in log units; mean ± SD
  5. eRange of neutralizing anti-HCV antibodies titers, expressed in log units